MediciNova Statistics
Total Valuation
MediciNova has a market cap or net worth of $67.44 million. The enterprise value is $32.28 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MediciNova has 49.05 million shares outstanding.
| Current Share Class | 49.05M |
| Shares Outstanding | 49.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.98% |
| Owned by Institutions (%) | 10.64% |
| Float | 42.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.38 |
| P/TBV Ratio | 1.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.66, with a Debt / Equity ratio of 0.00.
| Current Ratio | 17.66 |
| Quick Ratio | 17.14 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -20.33% and return on invested capital (ROIC) is -14.41%.
| Return on Equity (ROE) | -20.33% |
| Return on Assets (ROA) | -13.81% |
| Return on Invested Capital (ROIC) | -14.41% |
| Return on Capital Employed (ROCE) | -25.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$858,396 |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MediciNova has paid $5,537 in taxes.
| Income Tax | 5,537 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.17% in the last 52 weeks. The beta is 0.46, so MediciNova's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -3.17% |
| 50-Day Moving Average | 1.45 |
| 200-Day Moving Average | 1.72 |
| Relative Strength Index (RSI) | 42.63 |
| Average Volume (20 Days) | 12,732 |
Short Selling Information
The latest short interest is 188,359, so 0.38% of the outstanding shares have been sold short.
| Short Interest | 188,359 |
| Short Previous Month | 190,755 |
| Short % of Shares Out | 0.38% |
| Short % of Float | 0.45% |
| Short Ratio (days to cover) | 12.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.74M |
| Pretax Income | -8.16M |
| Net Income | -11.16M |
| EBITDA | -12.72M |
| EBIT | -12.74M |
| Earnings Per Share (EPS) | -$0.23 |
Full Income StatementBalance Sheet
The company has $36.57 million in cash and $189,860 in debt, giving a net cash position of $36.38 million or $0.74 per share.
| Cash & Cash Equivalents | 36.57M |
| Total Debt | 189,860 |
| Net Cash | 36.38M |
| Net Cash Per Share | $0.74 |
| Equity (Book Value) | 49.93M |
| Book Value Per Share | 1.02 |
| Working Capital | 35.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.56 million and capital expenditures -$895, giving a free cash flow of -$10.56 million.
| Operating Cash Flow | -10.56M |
| Capital Expenditures | -895 |
| Free Cash Flow | -10.56M |
| FCF Per Share | -$0.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |